<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006769" GROUP_ID="EYES" ID="224605021509500835" MERGED_FROM="" MODIFIED="2012-07-31 13:06:40 +0100" MODIFIED_BY="Anupa Shah" REVIEW_NO="FRBO01" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="4.0">
<COVER_SHEET MODIFIED="2012-07-31 13:06:40 +0100" MODIFIED_BY="Anupa Shah">
<TITLE>Interventions for late trabeculectomy bleb leak</TITLE>
<CONTACT MODIFIED="2012-07-31 13:06:40 +0100" MODIFIED_BY="Anupa Shah"><PERSON ID="38C7FF7F82E26AA20003EB8A318BC2D1" ROLE="AUTHOR"><FIRST_NAME>Frank</FIRST_NAME><LAST_NAME>Bochmann</LAST_NAME><SUFFIX>MD</SUFFIX><EMAIL_1>frank.bochmann@luks.ch</EMAIL_1><ADDRESS><DEPARTMENT>Department of Ophthalmology</DEPARTMENT><ORGANISATION>Cantonal Hospital of Lucerne</ORGANISATION><CITY>Lucerne</CITY><ZIP>CH-6000</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+41 (0) 41 205 33 09</PHONE_1><FAX_1>+41 (0) 41 205 34 06</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-07-31 13:06:40 +0100" MODIFIED_BY="Anupa Shah"><PERSON ID="38C7FF7F82E26AA20003EB8A318BC2D1" ROLE="AUTHOR"><FIRST_NAME>Frank</FIRST_NAME><LAST_NAME>Bochmann</LAST_NAME><SUFFIX>MD</SUFFIX><EMAIL_1>frank.bochmann@luks.ch</EMAIL_1><ADDRESS><DEPARTMENT>Department of Ophthalmology</DEPARTMENT><ORGANISATION>Cantonal Hospital of Lucerne</ORGANISATION><CITY>Lucerne</CITY><ZIP>CH-6000</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+41 (0) 41 205 33 09</PHONE_1><FAX_1>+41 (0) 41 205 34 06</FAX_1></ADDRESS></PERSON><PERSON ID="DC57AB8582E26AA201DAB7D8F29EDB4B" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Augusto</FIRST_NAME><LAST_NAME>Azuara-Blanco</LAST_NAME><SUFFIX>PhD, FRCS(Ed), FRCOphth</SUFFIX><POSITION>Honorary Consultant Ophthalmologist</POSITION><EMAIL_1>aazblanco@aol.com</EMAIL_1><MOBILE_PHONE>aazblanco@abdn.ac.uk</MOBILE_PHONE><ADDRESS><ORGANISATION>Health Services Research Unit, University of Aberdeen</ORGANISATION><ADDRESS_1>3rd Floor, Health Sciences Building</ADDRESS_1><ADDRESS_2>Foresterhill</ADDRESS_2><CITY>Aberdeen</CITY><ZIP>AB25 2ZD</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1224 552730</PHONE_1><FAX_1>+44 1224 554580</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-07-26 10:15:36 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="18" MONTH="7" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="18" MONTH="7" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="13" MONTH="8" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2009-12-02 14:59:44 +0000" MODIFIED_BY="Anupa Shah"/>
<HISTORY MODIFIED="2009-12-02 14:59:44 +0000" MODIFIED_BY="Anupa Shah">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-12-02 14:59:44 +0000" MODIFIED_BY="Anupa Shah">
<DATE DAY="12" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-07-31 12:59:08 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-07-31 12:50:41 +0100" MODIFIED_BY="Anupa Shah">
<TITLE MODIFIED="2009-12-02 15:23:14 +0000" MODIFIED_BY="Anupa Shah">Interventions for late trabeculectomy bleb leaks</TITLE>
<SUMMARY_BODY MODIFIED="2012-07-31 12:50:41 +0100" MODIFIED_BY="Anupa Shah">
<P>Trabeculectomy is an eye operation in which a drainage fistula is created in the wall of the eye to reduce intraocular pressure, which is the goal of treating glaucoma. The fluid drained from the eye forms a blister-like reservoir called "filtering bleb" where the fluid from the eye is then absorbed. Extensive scarring of the subconjunctival tissue leads to failure of the operation, therefore, drugs that inhibit cell growth and scar formation are used. Sometimes these drugs lead to thin walled and avascular filtering blebs, which are prone to leaks and infections. Such late-onset filtering blebs and associated infections are a dangerous and common complication after filtering glaucoma surgery. For late-onset bleb leaks, various treatments ranging from antibiotic eye drops to surgical closure of the leak have been suggested. The aim of this review was to compare any interventions to treat bleb leaks with conservative treatment and different interventions with each other. The literature search for this review identified only one randomised controlled trial (RCT) that compared two surgical techniques covering the leaking filtering bleb with different types of tissue. The two surgical techniques were (1) conjunctival advancement whereby the conjunctiva (tissue covering the sclera) is dissected and mobilised forward to cover the leaking area, and (2) amniotic membrane transplant. The amniotic membrane is a thin, transparent tissue covering the foetus in the womb that is obtained after birth.<BR/>
</P>
<P>Based on these findings it cannot be decided which intervention for filtering bleb leaks is the best, and whether an intervention is necessary at all. The authors' opinion is that in persistent bleb leaks, and those associated with sight threatening conditions such as hypotony (i.e. very low pressure in the eye), conjunctival advancement is the most promising procedure.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-07-30 15:23:04 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2009-08-14 14:51:54 +0100" MODIFIED_BY="Anupa Shah">
<P>Late trabeculectomy bleb leaks are a common complication after filtering glaucoma surgery. Although asymptomatic, late bleb leaks may lead to hypotony and are associated with bleb related infections.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-02-29 13:37:41 +0000" MODIFIED_BY="[Empty name]">
<P>To assess the effects of interventions for late trabeculectomy bleb leak.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-07-23 14:08:24 +0100" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (<I>The Cochrane Library</I> 2012, Issue 7), MEDLINE (January 1946 to July 2012), EMBASE (January 1980 to July 2012), the <I>meta</I>Register of Controlled Trials (<I>m</I>RCT) (<A HREF="http://www.controlled-trials.com">www.controlled-trials.com</A>), ClinicalTrials.gov (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>) and the WHO International Clinical Trials Registry Platform (ICTRP) (<A HREF="http://www.who.int/ictrp/search/en">www.who.int/ictrp/search/en</A>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 18 July 2012.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-02-29 13:37:56 +0000" MODIFIED_BY="[Empty name]">
<P>We included randomised and quasi-randomised trials in which any treatments for eyes with late bleb leak (interventional and non-interventional) were compared with each other.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-12-23 21:02:39 +0000" MODIFIED_BY="Anupa Shah">
<P>Two authors independently assessed trial quality and extracted data. We contacted study authors when additional information was needed.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-05-25 00:06:01 +0100" MODIFIED_BY="Anupa Shah">
<P>The review included one multicentre trial based in the USA with 30 eyes of 30 participants. The trial compared two surgical procedures (conjunctival advancement and amniotic membrane transplant) to cover a filtering bleb leak. Conjunctival advancement has been shown to be more effective in sealing filtering bleb leaks.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-07-30 15:23:04 +0100" MODIFIED_BY="Anupa Shah">
<P>Although a variety of treatments have been proposed for bleb leaks, there is no evidence of their comparative effectiveness.</P>
<P>The evidence in this review was provided by a single trial that compared two surgical procedures (conjunctival advancement and amniotic membrane transplant). The trial did show a superiority of conjunctival advancement, which was regarded as standard treatment, to amniotic membrane transplantation. There is a need for more randomised trials to validate the findings of this single trial and provide more information on the different types of interventions, especially non-surgical treatments compared to surgical procedures. We recommend that any intervention should be compared to a standard procedure, which is to date conjunctival advancement.<BR/>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-07-31 12:59:08 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-07-31 12:59:08 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2012-07-31 12:51:00 +0100" MODIFIED_BY="[Empty name]">
<P>Trabeculectomy is a surgical procedure for glaucoma in which a guarded fistula is created. This fistula allows aqueous humour to escape from the anterior chamber in to the subconjunctival space, where the fluid is reabsorbed through venous capillaries and lymphatics. The intervention was first described in 1968 in <LINK REF="REF-Cairns-1968" TYPE="REFERENCE">Cairns 1968</LINK>. Today, it is the most commonly performed surgical intervention for patients with glaucoma (which has not been sufficiently controlled with medication, laser treatment or both).<BR/>
</P>
<P>The accumulation of aqueous humour in the subconjunctival space forms a blister-like reservoir that is called a "filtering bleb". At this level, the conjunctiva is the only barrier preventing the entry of infectious micro-organisms into the eye. The filtering bleb may have different morphologic characteristics e.g. diffuse or localised, with a thin or thick wall, with single or multiple cavities etc.</P>
<P>An increased wound healing response with scarring of the episcleral tissue is the main reason for failure of filtration surgery. To enhance the success rate of filtration surgery, wound healing modifying agents such as 5-fluorouracil (5-FU) and mitomycin C (MMC) are widely used (<LINK REF="REF-Beckers-2003" TYPE="REFERENCE">Beckers 2003</LINK>; <LINK REF="REF-FFSSG-1996" TYPE="REFERENCE">FFSSG 1996</LINK>; <LINK REF="REF-Hagiwara-2000" TYPE="REFERENCE">Hagiwara 2000</LINK>; <LINK REF="REF-Kim-1998" TYPE="REFERENCE">Kim 1998</LINK>; <LINK REF="REF-Mietz-1998" TYPE="REFERENCE">Mietz 1998</LINK>; <LINK REF="REF-Wilkins-2005" TYPE="REFERENCE">Wilkins 2005</LINK>; <LINK REF="REF-Wormald-2001" TYPE="REFERENCE">Wormald 2001</LINK>; <LINK REF="REF-WuDunn-2002" TYPE="REFERENCE">WuDunn 2002</LINK>). These antifibrotic agents alter the morphologic and histologic appearance of filtering blebs (<LINK REF="REF-Crowston-2004" TYPE="REFERENCE">Crowston 2004</LINK>; <LINK REF="REF-Khaw-1992" TYPE="REFERENCE">Khaw 1992</LINK>). While filtering blebs after trabeculectomy, without antimetabolites, showed a normal epithelium and loosely arranged subepithelial connective tissue (<LINK REF="REF-Addicks-1983" TYPE="REFERENCE">Addicks 1983</LINK>), the examination of filtering blebs after the use of 5-FU or MMC showed a decreased epithelial thickness, a decreased number of goblet cells, as well as decreased vascularity of the subepithelial tissue (<LINK REF="REF-Anand-2006" TYPE="REFERENCE">Anand 2006</LINK>; <LINK REF="REF-Francis-2005" TYPE="REFERENCE">Francis 2005</LINK>; <LINK REF="REF-Mietz-1996" TYPE="REFERENCE">Mietz 1996</LINK>; <LINK REF="REF-Shields-1993" TYPE="REFERENCE">Shields 1993</LINK>; <LINK REF="REF-Sihota-2000" TYPE="REFERENCE">Sihota 2000</LINK>). Additionally, a dysfunctional conjunctival barrier with transconjunctival seepage, without point leak can occur (<LINK REF="REF-Sihota-2000" TYPE="REFERENCE">Sihota 2000</LINK>).<BR/>These changes may be associated with late-onset filtering bleb leaks that can cause severe postoperative complications such as hypotony and bleb-related endophthalmitis (<LINK REF="REF-DeBry-2002" TYPE="REFERENCE">DeBry 2002</LINK>; <LINK REF="REF-Greenfield-1998" TYPE="REFERENCE">Greenfield 1998</LINK>; <LINK REF="REF-Matsuo-2002" TYPE="REFERENCE">Matsuo 2002</LINK>).</P>
<P>Between 1998 and 2004, 33,697 trabeculectomies were performed in the UK alone (<LINK REF="REF-Fraser-2006" TYPE="REFERENCE">Fraser 2006</LINK>). Especially following the use of antifibrotic agents, the risk of developing point leak in avascular filtering blebs is high, with a reported probability of 1.8% (<LINK REF="REF-Anand-2006" TYPE="REFERENCE">Anand 2006</LINK>), 14.6% (<LINK REF="REF-Belyea-1997" TYPE="REFERENCE">Belyea 1997</LINK>) and 13.6% (<LINK REF="REF-Bindlish-2002" TYPE="REFERENCE">Bindlish 2002</LINK>) respectively at 24 months after surgery.</P>
<P>Late bleb leaks typically appear in localised, thin-walled, avascular filtering blebs. Late leakage of aqueous humour can either be focal or diffuse (e.g. transconjunctival leakage). It is detected by the Seidel test, with fluorescein drops or by painting the conjunctiva with a moistened fluorescein strip, using cobalt-blue light filtered illumination and slit-lamp biomicroscopy.<B> </B> </P>
<P>Although a late bleb leak may be asymptomatic, it is probably a major risk factor for bleb-related infections (<LINK REF="REF-Belyea-1997" TYPE="REFERENCE">Belyea 1997</LINK>; <LINK REF="REF-Greenfield-1996" TYPE="REFERENCE">Greenfield 1996</LINK>; <LINK REF="REF-Mac-2003" TYPE="REFERENCE">Mac 2003</LINK>; <LINK REF="REF-Phillips-1994" TYPE="REFERENCE">Phillips 1994</LINK>; <LINK REF="REF-Soltau-2000" TYPE="REFERENCE">Soltau 2000</LINK>). Direct access of tear fluid into the anterior chamber via a leaking filtering bleb has been documented (<LINK REF="REF-Gollamudi-1993" TYPE="REFERENCE">Gollamudi 1993</LINK>). Bleb-related ocular infections can affect initially only the filtering bleb or may involve the whole eye i.e. endophthalmitis, which is a severe and potentially devastating complication. Another potentially sight threatening consequence of late-onset filtering bleb leak is hypotony (<LINK REF="REF-Newhouse-1982" TYPE="REFERENCE">Newhouse 1982</LINK>). If a late bleb leak is detected, interventions are typically indicated to halt the leakage and to prevent further complications, even when the patient is asymptomatic at the moment of diagnosis.</P>
</CONDITION>
<INTERVENTION MODIFIED="2012-05-24 08:59:17 +0100" MODIFIED_BY="Anupa Shah">
<P>Different procedures are described to treat late-onset bleb leaks. Conservative management with topical antibiotics can be attempted as some bleb leaks may heal spontaneously. Surgical procedures reported in the literature are very diverse and include conjunctival advancement or transplantation (<LINK REF="REF-Budenz-1999" TYPE="REFERENCE">Budenz 1999</LINK>; <LINK REF="REF-Burnstein-2002" TYPE="REFERENCE">Burnstein 2002</LINK>; <LINK REF="REF-Harris-2000" TYPE="REFERENCE">Harris 2000</LINK>; <LINK REF="REF-Schnyder-2002" TYPE="REFERENCE">Schnyder 2002</LINK>; <LINK REF="REF-Wilson-1994" TYPE="REFERENCE">Wilson 1994</LINK>), scleral or corneal patch (<LINK REF="REF-Halkiadakis-2005" TYPE="REFERENCE">Halkiadakis 2005</LINK>; <LINK REF="REF-Kosmin-1997" TYPE="REFERENCE">Kosmin 1997</LINK>; <LINK REF="REF-Mistelberger-2001" TYPE="REFERENCE">Mistelberger 2001</LINK>), amniotic membrane transplantation (<LINK REF="STD-Budenz-2000" TYPE="STUDY">Budenz 2000</LINK>; <LINK REF="REF-Kee-2002" TYPE="REFERENCE">Kee 2002</LINK>), autologous blood, serum or fibrin glue injection (<LINK REF="REF-Asrani-1996" TYPE="REFERENCE">Asrani 1996</LINK>; <LINK REF="REF-Burnstein-2001" TYPE="REFERENCE">Burnstein 2001</LINK>; <LINK REF="REF-Kajiwara-1990" TYPE="REFERENCE">Kajiwara 1990</LINK>; <LINK REF="REF-Leen-1995" TYPE="REFERENCE">Leen 1995</LINK>), topical application of autologous serum drops (<LINK REF="REF-Matsuo-2005" TYPE="REFERENCE">Matsuo 2005</LINK>), application of cyanoacrylate tissue adhesive (<LINK REF="REF-Weber-1989" TYPE="REFERENCE">Weber 1989</LINK>; <LINK REF="REF-Zalta-1991" TYPE="REFERENCE">Zalta 1991</LINK>) as well as the use of laser treatment (<LINK REF="REF-Baum-1993" TYPE="REFERENCE">Baum 1993</LINK>; <LINK REF="REF-Hennis-1992" TYPE="REFERENCE">Hennis 1992</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2012-05-25 00:21:06 +0100" MODIFIED_BY="Anupa Shah">
<P>All interventions have the main goal of closing the leak and, in addition, they should preserve the function of the trabeculectomy. Interventions to treat late-onset bleb leaks may be divided into two different categories, according to their nature and mechanism of action.<BR/>
</P>
<OL>
<LI>Surgical procedures: the defect in the conjunctiva is covered surgically by transplanting or advancing tissue such as conjunctiva, sclera, cornea or amniotic membrane. These interventions might be used alone or in combination with each other. This type of intervention aims to seal the defect immediately.  </LI>
<LI>Non-surgical treatments: any other procedures such as injection of fibrin glue or autologous blood, application of cryotherapy or laser treatment to the leaking bleb. These treatments could mechanically close the fistula, induce a wound healing response in the subconjunctival space, or both. The topical application of substances that promote wound healing, such as autologous serum eye drops is also allocated to this category.</LI>
</OL>
</THEORY>
<IMPORTANCE MODIFIED="2012-07-31 12:59:08 +0100" MODIFIED_BY="Anupa Shah">
<P>Late-onset bleb leak is a complication of trabeculectomy that may lead to severe ocular infection and hypotony. The frequency of such complications may be increasing with the widespread use of antifibrotic agents. Various treatments have been reported in the literature (see<I> </I>
<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) and a systematic review is needed to identify and, if appropriate, summa rise any evidence of effectiveness of the different interventions, if possible identifying which is the most effective.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-05-24 08:59:36 +0100" MODIFIED_BY="Anupa Shah">
<OL>
<LI>To compare any interventions for late-onset bleb leaks after trabeculectomy, with conservative management consisting of observation, with or without prophylactic topical antibiotic therapy.</LI>
<LI>To compare the effectiveness of surgical treatment (i.e. covering the leak or surgical area with tissue) versus non-surgical interventions, mentioned above.</LI>
<LI>To compare the effectiveness of different surgical or non-surgical interventions (e.g. two different surgical treatments).</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2012-07-31 12:52:03 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-07-31 12:51:25 +0100" MODIFIED_BY="Anupa Shah">
<CRIT_STUDIES MODIFIED="2009-12-02 16:15:15 +0000" MODIFIED_BY="Anupa Shah">
<P>We included randomised controlled trials (RCTs) and quasi-RCTs.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-05-25 00:24:11 +0100" MODIFIED_BY="Anupa Shah">
<P>Participants in the trials were:</P>
<UL>
<LI>patients with a late-onset (i.e. more than three months after glaucoma surgery) bleb leak after trabeculectomy, associated or not with lens extraction or application of antifibrotic agents or both. The bleb leak may be symptomatic or asymptomatic, resulting from a localised defect (pinpoint leak) or a diffuse, trans-conjunctival seepage; and</LI>
<LI>patients with a history of blebitis or endophthalmitis in whom the infection has been controlled.</LI>
</UL>
<P>We excluded:</P>
<UL>
<LI>patients with late-onset bleb leak after other types of glaucoma surgery, such as deep sclerectomy, viscocanalostomy, or implantation of drainage devices. Participants can be asymptomatic, in whom the condition of a leaking filtering bleb is detected by chance, as well as symptomatic with tearing or reduced vision due to hypotony or both; and</LI>
<LI>patients with leaks due to a trauma (responsible for the conjunctival defect).</LI>
</UL>
<P>We imposed no restriction with respect to age, gender, race, comorbidities or number of participants.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-07-13 14:56:29 +0100" MODIFIED_BY="Anupa Shah">
<P>Any intervention designed to close a bleb leak. Conservative management (control group) consisted of observation, with or without topical lubrication, or topical antibiotics or both. Possible interventions were:</P>
<OL>
<LI>conjunctival advancement or transplantation;</LI>
<LI>scleral or corneal patch;</LI>
<LI>amniotic membrane transplantation;</LI>
<LI>autologous blood, serum or fibrin glue injection;</LI>
<LI>topical applications of autologous serum drops;</LI>
<LI>application of cyanoacrylate tissue adhesive; and</LI>
<LI>laser treatment.</LI>
</OL>
<P>The listed interventions may be categorised in some groups that follow different treatment principles. Conjunctival advancement, transplantation of conjunctiva or transplantation of amniotic membrane aim to seal the leak by covering the superficial defect with an additional tissue layer that, when healed in, restores the superficial integrity of the conjunctiva. When performing a conjunctival advancement, the avascular tissue of the filtering bleb is excised or de-epithelialised, the surrounding conjunctiva mobilised and sutured to the limbus.</P>
<P>Scleral or corneal patches are based on a different principle. The patch is sutured to the sclera over the defect in the deep tissue layers and helps to create additional outflow resistance. In addition, the patch guides the flow of aqueous away from the limbus. Commonly patches are combined with repair of the superficial tissue layers and would in addition induce an inflammatory and wound healing response that would also be beneficial.</P>
<P>The injection of autologous blood serum or fibrin glue into the tissue of the filtering bleb may seal the leak immediately by a clot or indirectly by inducing an inflammatory reaction with activation of a wound healing response.</P>
<P>Topical application of serum drops over a longer period supports the epithelialisation of the conjunctiva and might be used to treat small pinpoint leaks.</P>
<P>Cyanoacrylate adhesive polymerises when moistened. Applied directly to the leaking bleb a clot may seal the leak.  </P>
<P>Laser treatment induces a wound healing response and a shrinking of the filtering bleb. After painting the tissue surrounding the leak using methylene-blue the filtering bleb is treated with a Nd:YAG laser.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-07-31 12:51:25 +0100" MODIFIED_BY="Anupa Shah">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2012-05-24 06:44:23 +0100" MODIFIED_BY="Anupa Shah">
<OL>
<LI>Sealing of the bleb leak confirmed by a negative Seidel's test after one month, one year and five years.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2012-07-31 12:51:25 +0100" MODIFIED_BY="Anupa Shah">
<OL>
<LI>Recurrence of bleb leak within one year and five years.</LI>
<LI>Need for further intervention to control bleb leak within one year and five years.</LI>
<LI>Any surgical interventions to control glaucoma within one year and five years post-treatment.</LI>
<LI>Intraocular pressure and number of antiglaucoma medications at one year and five years after treatment.</LI>
<LI>Visual acuity as measured by logMAR method before bleb leak and before treatment, as well as at one and five years follow-up.</LI>
</OL>
<P>Although we set ideal follow-up times, we included trials with any length of follow-up.</P>
<SUBSECTION>
<HEADING LEVEL="4">Adverse outcomes</HEADING>
<P>We collected all reported systemic and ocular adverse events. The following adverse effects, in particular, were of interest.</P>
<OL>
<LI>Infection.</LI>
<LI>Loss of pressure control (defined by need for additional surgical treatment).</LI>
<LI>Loss of visual acuity (defined as doubling of logMAR, compared with both before leak and before treatment).</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Additional outcomes</HEADING>
<P>If economic or quality of life data were available from the selected studies, we mentioned these outcomes in the '<LINK TAG="DISCUSSION" TYPE="SECTION">Discussion</LINK>' section.</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-07-23 14:08:53 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2012-07-23 14:08:53 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2012, Issue 7, part of <I>The Cochrane Library</I>. <A HREF="http://www.thecochranelibrary.com">www.thecochranelibrary.com</A> (accessed 18 July 2012), MEDLINE (January 1946 to July 2012), EMBASE (January 1980 to July 2012), the <I>meta</I>Register of Controlled Trials (<I>m</I>RCT) (<A HREF="http://www.controlled-trials.com">www.controlled-trials.com</A>), ClinicalTrials.gov (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>) and the WHO International Clinical Trials Registry Platform (ICTRP) (<A HREF="http://www.who.int/ictrp/search/en">www.who.int/ictrp/search/en</A>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 18 July 2012.</P>
<P>See: Appendices for details of search strategies for CENTRAL (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), MEDLINE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), EMBASE (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>), <I>m</I>RCT (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>), ClinicalTrials.gov (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>) and the ICTRP (<LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-08-10 16:01:35 +0100" MODIFIED_BY="Anupa Shah">
<P>We searched the reference lists of the studies included in the review for information about further trials. We did not handsearch conference proceedings or journals specifically for the review.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-07-31 12:52:03 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-05-24 06:58:49 +0100" MODIFIED_BY="Anupa Shah">
<P>Both authors independently assessed the titles and abstracts of all reports identified by the electronic and manual searches. Each report was labelled A (definitely exclude), B (unsure) or C (definitely include). We reassessed full-text articles of abstracts labelled as 'unsure' according to the inclusion criteria for this review. We excluded studies labelled 'definitely exclude' from the review. We contacted the authors of studies labelled 'unsure' for further clarification. We assessed studies labelled as 'definitely include' for methodological quality. We resolved any differences between the two authors by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-05-24 07:00:39 +0100" MODIFIED_BY="Anupa Shah">
<P>Both authors extracted data using a paper form developed by the Cochrane Eyes and Vision Group. One author entered data into Review Manager 5 (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>) and the second author checked the data.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-05-25 00:28:34 +0100" MODIFIED_BY="[Empty name]">
<P>Both authors independently assessed the included studies for sources of systematic bias according to the guidelines in Chapter 8 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We evaluated the studies for the following criteria: random sequence generation and allocation concealment (selection bias), masking of outcome assessors (detection bias), and rates of follow-up and intention-to-treat (ITT) analysis (attrition bias). We assessed each study as low risk of bias, high risk of bias or unclear risk of bias.</P>
<UL>
<LI>Allocation concealment: we considered any reasonable method of allocation concealment (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) to be at low risk of bias. If the adequacy of allocation concealment was unclear from the trial report we contacted the primary investigators for clarification. If they did not respond within six weeks we classified the study based on available information and will update it as more information becomes available.</LI>
<LI>Masking of outcome assessors: masking of investigators and participants might not be possible with the interventions being examined, and so we did not assess this.</LI>
<LI>Rates of follow-up, reasons for loss to follow-up and analysis of the ITT principle. We considered a trial to have been analysed by ITT principles if it analysed participants as randomised and included participants for whom no outcome measurements were made, and analysed those who received only part or none of the intended treatment. If we detected that a study had performed available case analysis (without fulfilling the criteria of ITT) we still planned to perform a meta-analysis of this study.</LI>
</UL>
<P>We resolved disagreements through discussion and reached a consensus. We contacted the authors of the studies for additional information on issues that were categorised as 'unclear' from information available in the report. If there was a failure to communicate with the primary investigators, or if they did not respond within six weeks we assessed the methodological quality based on the available information.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-05-25 00:29:35 +0100" MODIFIED_BY="Anupa Shah">
<P>For the treatment effect we expected dichotomous data. After the intervention the leak is either sealed, or the leak persists, representing a failure of the procedure. We summarised dichotomous outcomes as risk ratios (RRs) and continuous outcomes as mean differences (MDs). We calculated standardised mean differences (SMDs) when outcomes were measured on different scales.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2012-05-28 21:21:26 +0100" MODIFIED_BY="Anupa Shah">
<P>To address the unit of analysis issue, we carefully assessed identified trials to see whether multiple treatment attempts may cause a unit of analysis error or, (although a bleb leak in both eyes is a rare condition and it is not expected to identify studies that include such patients), both eyes of a randomised patient received the same or a different treatment.<BR/>In case of multiple treatment attempts (or both eyes receiving the same treatment), we defined the sample size as number of participants (analogue as described for the analysis of cluster randomised trials).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2009-08-10 16:01:56 +0100" MODIFIED_BY="Anupa Shah">
<P>If it was not possible to extract all of the relevant information from the published reports we contacted the investigators to request individual patient data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2012-05-24 07:21:35 +0100" MODIFIED_BY="Anupa Shah">
<P>As only one trial was included, we could not assess heterogeneity.</P>
<P>In further updates, when additional trials are included, we will assess heterogeneity by careful review of the full-text paper. To quantify the impact of heterogeneity and assess inconsistency we will use the I<SUP>2 </SUP>statistic. Values of I<SUP>2</SUP> of 50% or greater are regarded as evidence for statistical heterogeneity. In this case, studies may not be combined for a meta-analysis and dividing the studies into subgroups may be considered.</P>
<P>If there is no statistical or clinical heterogeneity, and if the number of trials is fewer than three, we will use a fixed-effect model so as to avoid reporting less robust effect estimates that may result from random-effects models in situations with very few trials.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2012-07-31 12:52:03 +0100" MODIFIED_BY="Anupa Shah">
<P>If in the future a sufficient number of trials (10 or more) are included in the analysis, we will prepare a funnel plot using Review Manager 5 to look for signs of asymmetry.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-05-17 15:43:22 +0100" MODIFIED_BY="Anupa Shah">
<P>We planned the data analysis according to the guidelines set out in Chapter 9 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-05-25 14:00:49 +0100" MODIFIED_BY="Anupa Shah">
<P>In our review the treatment effect may vary with different treatment characteristics and a large number of population characteristics, as different types of interventions are investigated, and compared with the number of patients with bleb leak, the number of relevant underlying conditions is high. Therefore, it may be necessary to undertake subgroup analyses. Any subgroup analyses conducted within this review will be post-hoc.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-05-25 14:01:27 +0100" MODIFIED_BY="Anupa Shah">
<P>For future updates, where more trials are included in the review, we will examine the impact of excluding studies with lower methodological quality, unpublished data and industry-funded data in sensitivity analyses.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-07-31 12:52:41 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-07-23 14:10:47 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2012-07-23 14:10:47 +0100" MODIFIED_BY="[Empty name]">
<P>The electronic searches identified 950 reports of studies (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). The Trials Search Co-ordinator (TSC) scanned the search results and removed 661 references which were not relevant to the scope of the review. We screened the title and abstracts of the remaining 289 references. We rejected 288 abstracts as not eligible for inclusion in the review. We obtained a full-text copy of one report. This study met the inclusion criteria and is included in the review (<LINK REF="STD-Budenz-2000" TYPE="STUDY">Budenz 2000</LINK>). We did not find any quasi-randomised trials.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-05-29 10:07:43 +0100" MODIFIED_BY="Anupa Shah">
<P>See the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table for additional information.</P>
<SUBSECTION>
<HEADING LEVEL="3">Types of participants</HEADING>
<P>The trial included 30 eyes of 30 patients. All patients required surgical repair of a leaking filtering bleb beyond the three months postoperative period. Conservative measures had failed to close the leak. For the previous glaucoma filtering surgery, in 29 patients, an antifibrotic agent had been used. Twenty-one patients had been treated with mitomycin C (MMC), while eight patients had been treated with 5-fluorouracil (5-FU). Seven patients were white, 17 hispanic, and six patients were black. All bleb leaks were confirmed by a positive Seidel test. Thirteen patients had a previous bleb-related infection and 10 patients suffered from hypotony, defined by a pressure lower than 5 mmHg.  </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Types of interventions</HEADING>
<P>In this trial, patients with late bleb leak were randomised either to conjunctival advancement or amniotic membrane transplantation. In both techniques, the old filtering bleb was completely excised. For conjunctival advancement, adjacent conjunctival tissue was mobilised and the defect covered with vital tissue. For amniotic membrane transplantation, the adjacent conjunctival tissue was undermined, and preserved human amniotic membrane extending 2 mm under the surrounding conjunctiva and onto the cornea was sutured in place. The surgery was carried out under local anaesthesia.  </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Types of outcome measures</HEADING>
<P>Outcome measures were recurrence, or failure of the bleb leak to resolve. Other outcome measures included control of intraocular pressure, number of glaucoma medications, need for repeat glaucoma surgery and visual acuity. Results were reported at one week, one month, four months, six months and 12 months.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-05-25 00:39:26 +0100" MODIFIED_BY="Anupa Shah">
<P>We contacted the investigators of the included paper for further information on their study. A reply clarifying methodological issues was received. We will update this review with any additional information received.</P>
<P>Analysis was performed according to the ITT principle. One patient of the amniotic membrane transplant group who developed a recurrent leak was lost to follow-up after one year. We have contacted the investigators of this study to clarify these points. The power of the study was not estimated/reported.</P>
<ALLOCATION MODIFIED="2012-05-24 07:36:43 +0100" MODIFIED_BY="Anupa Shah">
<P>Allocation concealment (the process of treatment allocation whereby those recruiting participants and the participants themselves are unaware of the next assignment in the sequence and the allocation, once made, cannot be changed) is critical to avoid selection bias. Allocation concealment was not explicitly reported in the paper, but confirmed in the reply of the author. (Randomisation was carried out by putting the name of the two interventions on pieces of paper in opaque envelopes. These were randomly ordered and then numbered. As patients were enrolled, the next envelope was opened and the patient assigned.)</P>
</ALLOCATION>
<BLINDING MODIFIED="2009-12-02 15:03:25 +0000" MODIFIED_BY="Anupa Shah">
<P>Masking was considered to relate to masking of participants as to their intervention. Masking of the examiners assessing the postoperative results in this case was not realistically feasible as the two evaluated interventions look demonstrably different. This could potentially be a source of performance or detection bias.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-05-25 00:39:26 +0100" MODIFIED_BY="Anupa Shah">
<P>One patient in the amniotic membrane transplant group who developed a recurrent leak that persisted for three months was then lost to follow-up. The reason for loss of follow-up is unclear. However, the risk of attrition bias is low because this single case was detected to have recurrence of bleb leak.</P>
<P>A graph summary of all parameters is presented in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
</EXCLUSIONS>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-07-31 12:52:41 +0100" MODIFIED_BY="Anupa Shah">
<P>Fifteen patients received amniotic membrane transplant and 15 received conjunctival advancement. The average time between initial glaucoma surgery and revision for bleb leak was 40.6 +/- 22.9 months in the amniotic membrane transplant group and 30.5 +/- 10.8 months for the conjunctival advancement group. All patients were followed up for a minimum of one year. The average follow-up time was 19.5 +/- 6.9 months.</P>
<SUBSECTION>
<HEADING LEVEL="3">Recurrence of bleb leak</HEADING>
<P>The leak failed to close for four of the patients in the amniotic membrane transplant group. Two patients had persistent leakage from the first postoperative day, which required conjunctival advancement. One patient was successfully treated with this method, while the second patient developed persistent leakage due to retraction of the conjunctiva. This patient finally required closure of the trabeculectomy with a donor sclera patch graft combined with a glaucoma drainage implant. Two additional patients in the amniotic membrane transplant group developed late-onset bleb leaks. One of these two patients underwent closure of the trabeculectomy with a scleral patch graft combined with a glaucoma drainage implant 17 months after the bleb repair. The second patient had a persisting leak for three months and was then lost to follow-up. The cumulative survival rate for amniotic membrane transplant was 81% at six months, 74% at one year, and 46% at two years.</P>
<P>No patient in the conjunctival advancement group suffered from persistent or recurrent bleb leak. Therefore the cumulative survival rate was 100%.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Surgical interventions to control glaucoma</HEADING>
<P>Three patients in the amniotic membrane transplant group required repeat glaucoma surgery for uncontrolled intraocular pressure. Two patients underwent glaucoma drainage implant surgery (one patient at two months, and the other patient at two years following initial surgery) and the third underwent a repeat trabeculectomy with MMC.</P>
<P>One single patient from the conjunctival advancement group underwent reoperation for glaucoma. The patient underwent glaucoma drainage implant during a repeat corneal grafting due to failure of a previous corneal graft. The clinical outcome was successful by intraocular pressure criteria. Therefore, none of the patients in the conjunctival advancement group needed reoperation when intraocular pressure criteria were applied.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Visual acuity</HEADING>
<P>Overall, the visual acuity in both groups remained the same. Seven patients in the amniotic membrane transplant group lost 2 or more lines of vision versus 5 in the conjunctival advancement group. Three patients in each group gained 2 or more lines of vision.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pressure control</HEADING>
<P>The pressure was lower in the amniotic membrane transplant group at week one (P = 0.03) and week four (P = 0.04). There was no difference in intraocular pressure at any other follow-up time until the reported 24 months last follow-up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Number of antiglaucoma medications</HEADING>
<P>There was no difference in the number of antiglaucoma medications used at any time interval between the two intervention groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse outcomes</HEADING>
<P>A loss of visual acuity in some patients in both intervention groups was already described above.</P>
<P>One single patient in the conjunctival advancement group needed a reoperation for glaucoma during the study period. Nine months postoperatively, the patient developed failure of a previous corneal transplant and needed another penetrating keratoplasty combined with glaucoma drainage device implantation.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-07-31 12:53:16 +0100" MODIFIED_BY="Anupa Shah">
<P>The aim of this review was to answer the questions as to whether surgery is necessary for the treatment of late-onset filtering bleb leaks and, if so, which intervention offers the best results.</P>
<P>The literature search resulted in a large number of reports dealing with the problem of the treatment of late-onset filtering bleb leaks, however almost all of the studies were retrospective chart reviews with only a small number of patients.</P>
<P>The review of the literature offers a wide range of possible interventions for filtering bleb leaks. Up until now, no treatment of choice exists and different treatment strategies are used. In addition, leaking filtering blebs do not offer a homogenous picture as they differ in size, vascularity, grade of extension onto the cornea and intraocular pressure. Bleb leaks are sometimes associated with profound hypotony and decreased vision.</P>
<P>To simplify the situation, we categorised the interventions as described in the '<LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK>' section to surgical procedures (i.e. covering the leak or surgical area of the previous trabeculectomy with autologous or donor tissue) and non-surgical treatments.</P>
<P>We could only identify one single trial fulfilling the criteria of a RCT. In this trial, two surgical techniques to cover a leaking filtering bleb with tissue were compared. We did not find any RCTs comparing surgical procedures with non-surgical treatments, or any intervention compared with conservative treatment.</P>
<P>The single trial included in this study did show a superiority of conjunctival advancement, which was regarded as standard treatment, to amniotic membrane transplantation for closure of late-onset filtering bleb leaks. In the amniotic membrane transplant group significantly more persistent or recurrent filtering bleb leaks occurred while the intraocular pressure, the number of antiglaucoma medications and the visual acuity did not show a significant difference between the two intervention groups.</P>
<P>There is probably a bias towards treatment of more difficult, previously unsuccessful cases, as patients were included for whom previous conservative measures had failed to seal the filtering bleb leak.</P>
<P>Based on the results of this literature review, we cannot conclude which intervention for filtering bleb leaks is the best and whether non-surgical, non-operating room dependent treatments, such as injection of autologous blood or fibrin glue, are an effective alternative to conjunctival advancement.</P>
<P>This review was limited by the fact that only one trial was included. A meta-analysis of several trials would have allowed for a more precise and meaningful judgment. Further studies are needed to address this issue.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-07-13 15:11:16 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-07-12 20:51:52 +0100" MODIFIED_BY="Anupa Shah">
<P>The single trial in this review suggests that conjunctival advancement is a surgical intervention with high probability of sealing a filtering bleb leak in one step. Until further studies give evidence that alternative techniques are as effective as conjunctival advancement, this procedure should be regarded as the most promising treatment for late-onset filtering bleb leaks.</P>
<P>Whether non-surgical procedures offer a safe and effective alternative to conjunctival advancement remains unclear. Until more evidence is available, clinicians must decide based on their own experience.</P>
<P>Non-surgical procedures have the advantage that they can be done at the slit lamp, and therefore no access to an operating room is necessary. In selected cases a stepwise approach with an initial non-surgical attempt to seal the leak might be justified.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-07-13 15:11:16 +0100" MODIFIED_BY="[Empty name]">
<P>The combination of a quite rare condition with a wide variety of treatment approaches indicates that the most effective treatment has not been defined yet.</P>
<P>Filtering bleb leaks are a potentially sight threatening complication of glaucoma surgery and high quality RCTs are necessary to compare the different treatment approaches.</P>
<P>The best available evidence that has arisen from one single RCT comparing two surgical techniques and many uncontrolled studies points towards the superiority of a currently used surgical procedure, the conjunctival advancement.</P>
<P>There is need for more RCTs to validate the findings of this single trial and to provide more information on the different types of interventions, especially non-surgical treatments compared to surgical procedures.</P>
<P>The results of this specific study may leave investigators in a dilemma when planning further trials. It will be difficult to justify further trials with an amniotic membrane transplant group (although another trial would be required to validate such evidence) or trials in which surgical interventions are not compared to conjunctival advancement. In addition it simply does not make sense to compare the widely used alternative, non-surgical treatments with each other.</P>
<P>We therefore recommend that any intervention should be compared to a standard procedure, which is to date conjunctival advancement.</P>
<P>Entry criteria of the study should be clearly described and trials should include appropriate number of patients observed for a long enough follow up to address the different aspects of success, which are: persistent sealing of the leak and maintenance of pressure control.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-05-29 10:05:19 +0100" MODIFIED_BY="Anupa Shah">
<P>The electronic searches were prepared and executed by the Cochrane Eyes and Vision Group (CEVG) editorial team. We thank Catey Bunce, Dale Heuer and Amar Alwitry for their comments. We thank Anupa Shah, Managing Editor for CEVG for her assistance throughout the review process.</P>
<P>Richard Wormald (Co-ordinating Editor for CEVG) acknowledges financial support for his CEVG research sessions from the Department of Health (UK) through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-05-25 14:14:05 +0100" MODIFIED_BY="Anupa Shah">
<P>Conceiving the review: FB<BR/>Designing the review: FB, AAB<BR/>Co-ordinating the review: FB<BR/>Data collection for the review<BR/>- Designing search strategies: FB<BR/>- Undertaking searches: FB<BR/>- Screening search results: FB, AAB<BR/>- Organising retrieval of papers: FB<BR/>- Screening retrieved papers against inclusion criteria: FB, AAB<BR/>- Appraising quality of papers: FB<BR/>- Extracting data from papers: FB, AAB<BR/>- Writing to authors of papers for additional information: FB<BR/>- Obtaining and screening data on unpublished studies: FB<BR/>Data management for the review<BR/>- Entering data into RevMan: FB, AAB<BR/>Analysis of data: FB, AAB<BR/>Interpretation of data: FB, AAB<BR/>Providing a methodological perspective: FB<BR/>Providing a clinical perspective: FB<BR/>Providing a policy perspective: FB<BR/>Providing a consumer perspective: FB<BR/>Writing the review: FB, AAB<BR/>Providing general advice on the review: FB, AAB<BR/>Securing funding for the review: AAB<BR/>Performing previous work that was the foundation of the current study: AAB, FB<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2012-05-29 10:07:57 +0100" MODIFIED_BY="[Empty name]">
<P>As different treatments may be arranged into different groups (e.g. conservative treatment, non-surgical treatment and surgical treatment), we have modified the '<LINK TAG="OBJECTIVES" TYPE="SECTION">Objectives</LINK>' section to list the possible combinations of treatments that can be compared in studies.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-05-24 08:52:10 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2009-08-17 11:28:28 +0100" MODIFIED_BY="Anupa Shah">
<INCLUDED_STUDIES MODIFIED="2009-08-17 11:28:28 +0100" MODIFIED_BY="Anupa Shah">
<STUDY DATA_SOURCE="PUB" ID="STD-Budenz-2000" MODIFIED="2009-08-17 11:26:20 +0100" MODIFIED_BY="Anupa Shah" NAME="Budenz 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-08-17 11:26:20 +0100" MODIFIED_BY="Anupa Shah" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Budenz DL, Barton K, Tseng SC</AU>
<TI>Amniotic membrane transplantation for repair of leaking glaucoma filtering blebs</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2000</YR>
<VL>130</VL>
<NO>5</NO>
<PG>580-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-05-24 08:52:10 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-05-24 08:52:10 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Addicks-1983" NAME="Addicks 1983" TYPE="JOURNAL_ARTICLE">
<AU>Addicks EM, Quigley HA, Green WR, Robin AL</AU>
<TI>Histologic characteristics of filtering blebs in glaucomatous eyes</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1983</YR>
<VL>101</VL>
<NO>5</NO>
<PG>795-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anand-2006" NAME="Anand 2006" TYPE="JOURNAL_ARTICLE">
<AU>Anand N, Arora S, Clowes M</AU>
<TI>Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2006</YR>
<VL>92</VL>
<NO>2</NO>
<PG>175-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Asrani-1996" MODIFIED="2009-12-04 13:36:07 +0000" MODIFIED_BY="[Empty name]" NAME="Asrani 1996" TYPE="JOURNAL_ARTICLE">
<AU>Asrani SG, Wilensky JT</AU>
<TI>Management of bleb leaks after glaucoma filtering surgery. Use of autologous fibrin tissue glue as an alternative</TI>
<SO>Ophthalmology</SO>
<YR>1996</YR>
<VL>103</VL>
<NO>2</NO>
<PG>294-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Baum-1993" NAME="Baum 1993" TYPE="JOURNAL_ARTICLE">
<AU>Baum M, Weiss HS</AU>
<TI>Argon laser closure of conjunctival bleb leak</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1993</YR>
<VL>111</VL>
<NO>4</NO>
<PG>438</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beckers-2003" NAME="Beckers 2003" TYPE="JOURNAL_ARTICLE">
<AU>Beckers HJ, Kinders KC, Webers CA</AU>
<TI>Five-year results of trabeculectomy with mitomycin</TI>
<SO>Graefe's Archive for Clinical and Experimental Ophthalmology</SO>
<YR>2003</YR>
<VL>241</VL>
<NO>2</NO>
<PG>106-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belyea-1997" MODIFIED="2012-05-24 08:34:45 +0100" MODIFIED_BY="[Empty name]" NAME="Belyea 1997" TYPE="JOURNAL_ARTICLE">
<AU>Belyea DA, Dan JA, Stamber FL, Liebermann MF, Spencer WH</AU>
<TI>Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1997</YR>
<VL>124</VL>
<NO>1</NO>
<PG>40-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bindlish-2002" NAME="Bindlish 2002" TYPE="JOURNAL_ARTICLE">
<AU>Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, Lehrer R</AU>
<TI>Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow up</TI>
<SO>Ophthalmology</SO>
<YR>2002</YR>
<VL>109</VL>
<NO>7</NO>
<PG>1336-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Budenz-1999" MODIFIED="2012-05-24 08:35:33 +0100" MODIFIED_BY="[Empty name]" NAME="Budenz 1999" TYPE="JOURNAL_ARTICLE">
<AU>Budenz DL, Chen PP, Weaver YK</AU>
<TI>Conjunctival advancement for late-onset filtering bleb leaks: indications and outcome</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1999</YR>
<VL>117</VL>
<NO>8</NO>
<PG>1014-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burnstein-2001" NAME="Burnstein 2001" TYPE="JOURNAL_ARTICLE">
<AU>Burnstein A, WuDunn D, Ishii Y, Jonescu-Cuypers C, Cantor LB</AU>
<TI>Autologous blood injection for late-onset filtering bleb leak</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2001</YR>
<VL>132</VL>
<NO>1</NO>
<PG>36-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burnstein-2002" MODIFIED="2009-08-17 11:28:25 +0100" MODIFIED_BY="Anupa Shah" NAME="Burnstein 2002" TYPE="JOURNAL_ARTICLE">
<AU>Burnstein AL, WuDunn D, Knotts SL, Catoira Y, Cantor LB</AU>
<TI>Conjunctival advancement versus nonincisional treatment for late-onset glaucoma filtering bleb leaks</TI>
<SO>Ophthalmology</SO>
<YR>2002</YR>
<VL>109</VL>
<NO>1</NO>
<PG>71-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cairns-1968" MODIFIED="2009-12-04 13:35:36 +0000" MODIFIED_BY="[Empty name]" NAME="Cairns 1968" TYPE="JOURNAL_ARTICLE">
<AU>Cairns JE</AU>
<TI>Trabeculectomy, preliminary report of a new method</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1968</YR>
<VL>66</VL>
<NO>4</NO>
<PG>673-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Crowston-2004" NAME="Crowston 2004" TYPE="JOURNAL_ARTICLE">
<AU>Crowston JG, Chang LH, Daniels JT, Khaw PT, Akbar AN</AU>
<TI>T lymphocyte mediated lysis of mitomycin C treated Tenon's capsule fibroblasts</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2004</YR>
<VL>88</VL>
<NO>3</NO>
<PG>399-405</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DeBry-2002" NAME="DeBry 2002" TYPE="JOURNAL_ARTICLE">
<AU>DeBry PW, Perkins TW, Heatley P, Brumback LC</AU>
<TI>Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin</TI>
<SO>Archives of Ophthalmology</SO>
<YR>2002</YR>
<VL>120</VL>
<NO>3</NO>
<PG>297-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2012-05-24 08:37:13 +0100" MODIFIED_BY="[Empty name]" NAME="Deeks 2011" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses</TI>
<SO>In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FFSSG-1996" MODIFIED="2009-12-04 13:48:57 +0000" MODIFIED_BY="[Empty name]" NAME="FFSSG 1996" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1996</YR>
<VL>121</VL>
<NO>4</NO>
<PG>349-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Francis-2005" NAME="Francis 2005" TYPE="JOURNAL_ARTICLE">
<AU>Francis BA, Du LT, Najafi K, Murthy R, Kurumety U, Rao N, et al</AU>
<TI>Histopathologic features of conjunctival filtering blebs</TI>
<SO>Archives of Ophthalmology</SO>
<YR>2005</YR>
<VL>123</VL>
<NO>2</NO>
<PG>166-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fraser-2006" MODIFIED="2009-12-04 13:51:13 +0000" MODIFIED_BY="[Empty name]" NAME="Fraser 2006" TYPE="JOURNAL_ARTICLE">
<AU>Fraser SG, Wormald RP</AU>
<TI>Hospital Episode Statistics and changing trends in glaucoma surgery</TI>
<SO>Eye</SO>
<YR>2006</YR>
<VL>22</VL>
<NO>1</NO>
<PG>3-7</PG>
<IDENTIFIERS MODIFIED="2009-12-04 13:49:30 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Glanville-2006" NAME="Glanville 2006" TYPE="JOURNAL_ARTICLE">
<AU>Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J</AU>
<TI>How to identify randomized controlled trials in MEDLINE: ten years on</TI>
<SO>Journal of the Medical Library Association</SO>
<YR>2006</YR>
<VL>94</VL>
<NO>2</NO>
<PG>130-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gollamudi-1993" NAME="Gollamudi 1993" TYPE="JOURNAL_ARTICLE">
<AU>Gollamudi SR, Hodapp EA, Cubillas A, Culbertson WW</AU>
<TI>Photographically documented access of tear film to the anterior chamber through a leaky filtering bleb</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1993</YR>
<VL>111</VL>
<NO>3</NO>
<PG>394-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greenfield-1996" MODIFIED="2009-12-04 14:15:05 +0000" MODIFIED_BY="[Empty name]" NAME="Greenfield 1996" TYPE="JOURNAL_ARTICLE">
<AU>Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmber PF, Flynn HW</AU>
<TI>Endophthalmitis after filtering surgery with mitomycin</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1996</YR>
<VL>114</VL>
<NO>8</NO>
<PG>949-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greenfield-1998" NAME="Greenfield 1998" TYPE="JOURNAL_ARTICLE">
<AU>Greenfield DS, Liebmann JM, Lee J, Rich R</AU>
<TI>Late-onset bleb leaks after glaucoma filtering surgery</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1998</YR>
<VL>116</VL>
<NO>4</NO>
<PG>443-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hagiwara-2000" NAME="Hagiwara 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hagiwara Y, Yamamoto T, Kitazawa Y</AU>
<TI>The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma</TI>
<SO>Graefe's Archive for Clinical and Experimental Ophthalmology</SO>
<YR>2000</YR>
<VL>238</VL>
<NO>3</NO>
<PG>232-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Halkiadakis-2005" MODIFIED="2012-05-24 08:41:27 +0100" MODIFIED_BY="[Empty name]" NAME="Halkiadakis 2005" TYPE="JOURNAL_ARTICLE">
<AU>Halkiadakis I, Lim P, Moroi SE</AU>
<TI>Surgical results of bleb revision with scleral patch graft for late-onset bleb complications</TI>
<SO>Ophthalmic Surgery, Lasers and Imaging</SO>
<YR>2005</YR>
<VL>36</VL>
<NO>1</NO>
<PG>14-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harris-2000" MODIFIED="2012-05-24 08:41:36 +0100" MODIFIED_BY="[Empty name]" NAME="Harris 2000" TYPE="JOURNAL_ARTICLE">
<AU>Harris LD, Yang G, Feldmann RM, Fellman RL, Starita RY, Lynn J, et al</AU>
<TI>Autologous conjunctival resurfacing of leaking filtering blebs</TI>
<SO>Ophthalmology</SO>
<YR>2000</YR>
<VL>107</VL>
<NO>9</NO>
<PG>1675-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hennis-1992" NAME="Hennis 1992" TYPE="JOURNAL_ARTICLE">
<AU>Hennis HL, Stewart WC</AU>
<TI>Use of the argon laser to close filtering bleb leaks</TI>
<SO>Graefe's Archive for Clinical and Experimental Ophthalmology</SO>
<YR>1992</YR>
<VL>230</VL>
<NO>6</NO>
<PG>537-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-05-24 08:42:36 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies</TI>
<SO>In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kajiwara-1990" NAME="Kajiwara 1990" TYPE="JOURNAL_ARTICLE">
<AU>Kajiwara K</AU>
<TI>Repair of leaking bleb with fibrin glue</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1990</YR>
<VL>109</VL>
<NO>5</NO>
<PG>599-601</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kee-2002" NAME="Kee 2002" TYPE="JOURNAL_ARTICLE">
<AU>Kee C, Hwang JM</AU>
<TI>Amniotic membrane graft for late-onset glaucoma filtering leaks</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2002</YR>
<VL>133</VL>
<NO>6</NO>
<PG>834-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Khaw-1992" NAME="Khaw 1992" TYPE="JOURNAL_ARTICLE">
<AU>Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G</AU>
<TI>Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1992</YR>
<VL>110</VL>
<NO>8</NO>
<PG>1150-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kim-1998" NAME="Kim 1998" TYPE="JOURNAL_ARTICLE">
<AU>Kim YY, Sexton RM, Shin DH, Kim CH, Dinde SA, Ren J, et al</AU>
<TI>Outcomes of primary phakic trabeculectomies without versus with 0.5-to 1-minute versus 3-to 5-minute mitomycin C</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1998</YR>
<VL>126</VL>
<NO>6</NO>
<PG>755-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kosmin-1997" MODIFIED="2009-12-04 14:26:47 +0000" MODIFIED_BY="[Empty name]" NAME="Kosmin 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kosmin AS, Wishart PK</AU>
<TI>A full-thickness scleral graft for the surgical management of a late filtration bleb leak</TI>
<SO>Ophthalmic Surgery and Lasers</SO>
<YR>1997</YR>
<VL>28</VL>
<NO>6</NO>
<PG>461-8</PG>
<IDENTIFIERS MODIFIED="2009-12-04 14:26:47 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Leen-1995" NAME="Leen 1995" TYPE="JOURNAL_ARTICLE">
<AU>Leen MM, Moster MR, Kath LJ, Terebuh AK, Schmidt CM, Spaeth GL</AU>
<TI>Management of overfiltering and leaking blebs with autologous blood injection</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1995</YR>
<VL>113</VL>
<NO>8</NO>
<PG>1050-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mac-2003" NAME="Mac 2003" TYPE="JOURNAL_ARTICLE">
<AU>Mac I, Soltau JB</AU>
<TI>Glaucoma-filtering bleb infections</TI>
<SO>Current Opinion in Ophthalmology</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>2</NO>
<PG>91-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mandal-2001" MODIFIED="2008-07-12 15:49:17 +0100" MODIFIED_BY="Anupa Shah" NAME="Mandal 2001" TYPE="JOURNAL_ARTICLE">
<AU>Mandal AK</AU>
<TI>Management of the late leaking filtration blebs. A report of seven cases and a selective review of the literature</TI>
<SO>Indian Journal of Ophthalmology</SO>
<YR>2001</YR>
<VL>49</VL>
<NO>4</NO>
<PG>247-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matsuo-2002" MODIFIED="2009-12-04 14:24:01 +0000" MODIFIED_BY="[Empty name]" NAME="Matsuo 2002" TYPE="JOURNAL_ARTICLE">
<AU>Matsuo H, Tomidokoro A, Suzuki Y, Shirato S, Araie M</AU>
<TI>Late-onset transconjunctival oozing and point leak of aqueous humor from filtering bleb after trabeculectomy</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2002</YR>
<VL>133</VL>
<NO>4</NO>
<PG>456-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matsuo-2005" NAME="Matsuo 2005" TYPE="JOURNAL_ARTICLE">
<AU>Matsuo H, Tomidokoro A, Tomita G, Araie M</AU>
<TI>Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb</TI>
<SO>Eye</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>1</NO>
<PG>23-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mietz-1996" NAME="Mietz 1996" TYPE="JOURNAL_ARTICLE">
<AU>Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Kriegelstein GK</AU>
<TI>Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C</TI>
<SO>Graefe's Archive for Clinical and Experimental Ophthalmology</SO>
<YR>1996</YR>
<VL>234</VL>
<NO>6</NO>
<PG>364-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mietz-1998" MODIFIED="2009-12-04 14:26:29 +0000" MODIFIED_BY="[Empty name]" NAME="Mietz 1998" TYPE="JOURNAL_ARTICLE">
<AU>Mietz H, Kriegelstein GK</AU>
<TI>Three-year follow up of trabeculectomies performed with different concentrations of mitomycin C</TI>
<SO>Ophthalmic Surgery and Lasers</SO>
<YR>1998</YR>
<VL>29</VL>
<NO>8</NO>
<PG>628-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mistelberger-2001" MODIFIED="2009-12-04 14:28:44 +0000" MODIFIED_BY="[Empty name]" NAME="Mistelberger 2001" TYPE="JOURNAL_ARTICLE">
<AU>Mistelberger A, Biowski R, Grabner G</AU>
<TI>Repair of a late-onset filtering bleb leak using a corneal graft shaped with an excimer laser</TI>
<SO>Ophthalmic Surgery and Lasers</SO>
<YR>2001</YR>
<VL>32</VL>
<NO>5</NO>
<PG>428-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newhouse-1982" MODIFIED="2012-05-24 08:47:56 +0100" MODIFIED_BY="[Empty name]" NAME="Newhouse 1982" TYPE="JOURNAL_ARTICLE">
<AU>Newhouse RP, Beyrer C</AU>
<TI>Hypotony as a late complication of trabeculectomy</TI>
<SO>Annals of Ophthalmology</SO>
<YR>1982</YR>
<VL>14</VL>
<NO>7</NO>
<PG>685-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Phillips-1994" NAME="Phillips 1994" TYPE="JOURNAL_ARTICLE">
<AU>Phillips WB, Wong TP, Bergren RL, Friedberg MA, Benson WE</AU>
<TI>Late onset endophthalmitis associated with filtering blebs</TI>
<SO>Ophthalmic Surgery</SO>
<YR>1994</YR>
<VL>25</VL>
<NO>2</NO>
<PG>88-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2011" MODIFIED="2012-05-24 07:00:39 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schnyder-2002" NAME="Schnyder 2002" TYPE="JOURNAL_ARTICLE">
<AU>Schnyder CC, Shaarawy T, Ravinet E, Achache F, Uffer S, Mermoud A</AU>
<TI>Free conjunctival autologous graft for bleb repair and bleb reduction after trabeculectomy and nonpenetrating filtering surgery</TI>
<SO>Journal of Glaucoma</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>1</NO>
<PG>10-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shields-1993" NAME="Shields 1993" TYPE="JOURNAL_ARTICLE">
<AU>Shields MB, Scroggs MW, Sloop CM, Simmons RB</AU>
<TI>Clinical and histopathologic observation concerning hypotony after trabeculectomy with adjunctive mitomycin C</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1993</YR>
<VL>116</VL>
<NO>6</NO>
<PG>673-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sihota-2000" NAME="Sihota 2000" TYPE="JOURNAL_ARTICLE">
<AU>Sihota R, Dada T, Gupta SD, Sharma S, Arora R, Agarwal HC</AU>
<TI>Conjunctival dysfunction and mitomycin C-induced hypotony</TI>
<SO>Journal of Glaucoma</SO>
<YR>2000</YR>
<VL>9</VL>
<NO>5</NO>
<PG>392-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Soltau-2000" NAME="Soltau 2000" TYPE="JOURNAL_ARTICLE">
<AU>Soltau JB, Rothman RF, Budenz DL, Greenfield DS, Feuer W, Liebmann JM, et al</AU>
<TI>Risk factors for glaucoma filtering bleb infections</TI>
<SO>Archives of Ophthalmology</SO>
<YR>2000</YR>
<VL>118</VL>
<NO>3</NO>
<PG>338-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wadhwani-2000" MODIFIED="2008-07-12 15:46:49 +0100" MODIFIED_BY="Anupa Shah" NAME="Wadhwani 2000" TYPE="JOURNAL_ARTICLE">
<AU>Wadhwani RA, Bellows AR, Hutchinson BT</AU>
<TI>Surgical repair of leaking filtering blebs</TI>
<SO>Ophthalmology</SO>
<YR>2000</YR>
<VL>107</VL>
<NO>9</NO>
<PG>1681-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weber-1989" NAME="Weber 1989" TYPE="JOURNAL_ARTICLE">
<AU>Weber PA, Baker ND</AU>
<TI>The use of cyanoacrylate adhesive with a collagen shield in leaking filtering blebs</TI>
<SO>Ophthalmic Surgery</SO>
<YR>1989</YR>
<VL>20</VL>
<NO>4</NO>
<PG>284-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilkins-2005" MODIFIED="2012-05-24 08:50:09 +0100" MODIFIED_BY="[Empty name]" NAME="Wilkins 2005" TYPE="COCHRANE_REVIEW">
<AU>Wilkins M, Indar A, Wormald R</AU>
<TI>Intra-operative mitomycin C for glaucoma surgery</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2012-05-17 15:24:25 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-05-17 15:24:25 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002897.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wilson-1994" NAME="Wilson 1994" TYPE="JOURNAL_ARTICLE">
<AU>Wilson MR, Kotas-Neumann R</AU>
<TI>Free conjunctival patch for repair of persistent late bleb leak</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1994</YR>
<VL>117</VL>
<NO>5</NO>
<PG>569-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wormald-2001" MODIFIED="2012-05-24 08:51:46 +0100" MODIFIED_BY="[Empty name]" NAME="Wormald 2001" TYPE="COCHRANE_REVIEW">
<AU>Wormald R, Wilkins M, Bunce C</AU>
<TI>Postoperative 5-fluorouracil for glaucoma surgery</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-05-17 15:27:40 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-05-17 15:27:40 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001132"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-WuDunn-2002" MODIFIED="2012-05-24 08:52:10 +0100" MODIFIED_BY="[Empty name]" NAME="WuDunn 2002" TYPE="JOURNAL_ARTICLE">
<AU>WuDunn D, Cantor LB, Palanca-Capistrano AM, Hoop J, Alvi NP, Finley CH, et al</AU>
<TI>A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2002</YR>
<VL>134</VL>
<NO>4</NO>
<PG>521-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zalta-1991" MODIFIED="2009-12-04 14:47:06 +0000" MODIFIED_BY="[Empty name]" NAME="Zalta 1991" TYPE="JOURNAL_ARTICLE">
<AU>Zalta AH, Wieder RH</AU>
<TI>Closure of leaking filtering blebs with cyanoacrylate tissue adhesive</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>1991</YR>
<VL>75</VL>
<NO>3</NO>
<PG>170-3</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-07-31 12:54:20 +0100" MODIFIED_BY="Anupa Shah">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-07-31 12:54:20 +0100" MODIFIED_BY="Anupa Shah" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-05-28 21:02:49 +0100" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Budenz-2000">
<CHAR_METHODS MODIFIED="2012-05-24 08:11:54 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, multicentre trial with follow-up of at least 1 year</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-24 08:25:16 +0100" MODIFIED_BY="Anupa Shah">
<P>30 eyes of 30 participants<BR/>white n = 7 (23%), hispanic n = 17 (57%), black n = 6 (20%)<BR/>male n = 13 (43%), female n = 17 (57%)</P>
<P>mean age: 61.6 years</P>
<P>amniotic membrane group n = 15, conjunctival advancement group n = 15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-29 13:36:31 +0000" MODIFIED_BY="Anupa Shah">
<P>Complete excision of the old filtering bleb and undermining of the adjacent conjunctiva was performed. Sutures were added to the trabeculectomy flap if excessive flow or shallow anterior chamber was noted. In the amniotic membrane group, a piece of preserved human amniotic membrane (Biotissue, Miami, Florida) was placed over the defect reaching 2 mm under the surrounding conjunctiva and sutured to the cornea and conjunctiva. In the conjunctival advancement group, the conjunctiva was mobilised and then sutured to the limbus</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-28 21:02:49 +0100" MODIFIED_BY="[Empty name]">
<P>Intraocular pressure, number of antiglaucoma medications, reoperation for glaucoma or persistent or recurrent bleb leak</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-08-31 15:57:42 +0100" MODIFIED_BY="[Empty name]">
<P>Study supported by a grant for Research to Prevent Blindness, New York</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-07-31 12:54:20 +0100" MODIFIED_BY="Anupa Shah">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-07-31 12:54:20 +0100" MODIFIED_BY="Anupa Shah" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-31 12:54:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Budenz-2000">
<DESCRIPTION>
<P>Randomisation was carried out by putting the name of the two interventions on a piece of paper in opaque envelopes. These were randomly ordered and then numbered. As participants were enrolled, the next envelope was enrolled and the participant assigned (obtained from direct communication with study authors)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-12-24 22:20:59 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-24 22:20:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Budenz-2000">
<DESCRIPTION>
<P>See random sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-02-29 13:36:46 +0000" MODIFIED_BY="Anupa Shah" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>Outcome assessors</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-02-29 13:36:46 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Budenz-2000">
<DESCRIPTION>
<P>Masking of examiners assessing the postoperative results was not realistically feasible as the two interventions look demonstrably different</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="GROUP" NO="9">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" NO="10">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2012-07-31 12:54:05 +0100" MODIFIED_BY="Anupa Shah" NO="7">
<NAME>Rates of follow up</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-31 12:54:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Budenz-2000">
<DESCRIPTION>
<P>Loss of follow-up in only one participant after one year</P>
<P>Recurrence of the treated condition was detected before loss of follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2012-05-25 14:33:31 +0100" MODIFIED_BY="Anupa Shah" NO="8">
<NAME>Reasons for loss to follow-up</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-29 13:36:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Budenz-2000">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2012-05-24 08:31:26 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-05-24 08:31:26 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-05-24 08:30:33 +0100" MODIFIED_BY="[Empty name]">Interventions for late-onset bleb leaks</TITLE>
<TABLE COLS="2" ROWS="11">
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Studies</P>
</TH>
</TR>
<TR>
<TD>
<P>Conjunctival advancement</P>
</TD>
<TD>
<P>
<LINK REF="REF-Budenz-1999" TYPE="REFERENCE">Budenz 1999</LINK>; <LINK REF="REF-Burnstein-2002" TYPE="REFERENCE">Burnstein 2002</LINK>; <LINK REF="REF-Harris-2000" TYPE="REFERENCE">Harris 2000</LINK>; <LINK REF="REF-Mandal-2001" TYPE="REFERENCE">Mandal 2001</LINK>; <LINK REF="REF-Wadhwani-2000" TYPE="REFERENCE">Wadhwani 2000</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Free conjunctival patch</P>
</TD>
<TD>
<P>
<LINK REF="REF-Schnyder-2002" TYPE="REFERENCE">Schnyder 2002</LINK>; <LINK REF="REF-Wilson-1994" TYPE="REFERENCE">Wilson 1994</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Topical autologous serum</P>
</TD>
<TD>
<P>
<LINK REF="REF-Matsuo-2005" TYPE="REFERENCE">Matsuo 2005</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Autologous blood injection</P>
</TD>
<TD>
<P>
<LINK REF="REF-Burnstein-2001" TYPE="REFERENCE">Burnstein 2001</LINK>; <LINK REF="REF-Leen-1995" TYPE="REFERENCE">Leen 1995</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibrin glue injection</P>
</TD>
<TD>
<P>
<LINK REF="REF-Kajiwara-1990" TYPE="REFERENCE">Kajiwara 1990</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Full thickness scleral graft</P>
</TD>
<TD>
<P>
<LINK REF="REF-Halkiadakis-2005" TYPE="REFERENCE">Halkiadakis 2005</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Corneal graft</P>
</TD>
<TD>
<P>
<LINK REF="REF-Mistelberger-2001" TYPE="REFERENCE">Mistelberger 2001</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Amniotic membrane graft</P>
</TD>
<TD>
<P>
<LINK REF="REF-Kee-2002" TYPE="REFERENCE">Kee 2002</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Cyanoacrylate tissue adhesive</P>
</TD>
<TD>
<P>
<LINK REF="REF-Weber-1989" TYPE="REFERENCE">Weber 1989</LINK>; <LINK REF="REF-Zalta-1991" TYPE="REFERENCE">Zalta 1991</LINK>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Argon laser treatment</P>
</TD>
<TD>
<P>
<LINK REF="REF-Baum-1993" TYPE="REFERENCE">Baum 1993</LINK>; <LINK REF="REF-Hennis-1992" TYPE="REFERENCE">Hennis 1992</LINK>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES MODIFIED="2012-07-31 12:54:21 +0100" MODIFIED_BY="Anupa Shah">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-07-26 11:03:53 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Results from searching for studies for inclusion in the review.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAbkAAAH+CAYAAAABCXD8AAAYvElEQVR42u3d23KrSLZAUf//T1e/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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-07-31 12:54:21 +0100" MODIFIED_BY="Anupa Shah" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAPcAAAE4CAIAAAAIJ/LRAAALCUlEQVR42u3dv25kxRLH8ZFICBxs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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-07-23 14:17:13 +0100" MODIFIED_BY="Anupa Shah">
<APPENDIX ID="APP-01" MODIFIED="2008-07-12 15:36:33 +0100" MODIFIED_BY="Anupa Shah" NO="1">
<TITLE MODIFIED="2008-07-12 15:35:50 +0100" MODIFIED_BY="Anupa Shah">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-12 15:36:33 +0100" MODIFIED_BY="Anupa Shah">
<P>#1 MeSH descriptor Trabeculectomy<BR/>#2 trabeculectom*<BR/>#3 MeSH descriptor Filtering Surgery<BR/>#4 filter* near surg*<BR/>#5 filtrat* near surg*<BR/>#6 filter* near bleb*<BR/>#7 filtrat* near bleb*<BR/>#8 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7)<BR/>#9 leak*<BR/>#10 fail*<BR/>#11 ooz*<BR/>#12 (#9 OR #10 OR #11)<BR/>#13 (#8 AND #12)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-02-16 11:34:56 +0000" MODIFIED_BY="Anupa Shah" NO="2">
<TITLE MODIFIED="2008-07-12 15:36:17 +0100" MODIFIED_BY="Anupa Shah">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-02-16 11:34:56 +0000" MODIFIED_BY="Anupa Shah">
<P>1. randomized controlled trial.pt.<BR/>2. (randomized or randomised).ab,ti.<BR/>3. placebo.ab,ti.<BR/>4. dt.fs.<BR/>5. randomly.ab,ti.<BR/>6. trial.ab,ti.<BR/>7. groups.ab,ti.<BR/>8. or/1-7<BR/>9. exp animals/<BR/>10. exp humans/<BR/>11. 9 not (9 and 10)<BR/>12. 8 not 11<BR/>13. exp trabeculectomy/<BR/>14. trabeculectom$.tw.<BR/>15. exp filtering surgery/<BR/>16. (filter$ adj3 surg$).tw.<BR/>17. (filtrat$ adj3 surg$).tw.<BR/>18. (filter$ adj3 bleb$).tw.<BR/>19. (filtrat$ adj3 bleb$).tw.<BR/>20. or/13-19<BR/>21. leak$.tw.<BR/>22. fail$.tw.<BR/>23. ooz$.tw.<BR/>24. or/21-23<BR/>25. 20 and 24<BR/>26. 12 and 25</P>
<P>The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville (<LINK REF="REF-Glanville-2006" TYPE="REFERENCE">Glanville 2006</LINK>).</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2008-07-12 15:36:52 +0100" MODIFIED_BY="Anupa Shah" NO="3">
<TITLE MODIFIED="2008-07-12 15:36:45 +0100" MODIFIED_BY="Anupa Shah">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-12 15:36:52 +0100" MODIFIED_BY="Anupa Shah">
<P>1. exp randomized controlled trial/<BR/>2. exp randomization/<BR/>3. exp double blind procedure/<BR/>4. exp single blind procedure/<BR/>5. random$.tw.<BR/>6. or/1-5<BR/>7. (animal or animal experiment).sh.<BR/>8. human.sh.<BR/>9. 7 and 8<BR/>10. 7 not 9<BR/>11. 6 not 10<BR/>12. exp clinical trial/<BR/>13. (clin$ adj3 trial$).tw.<BR/>14. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.<BR/>15. exp placebo/<BR/>16. placebo$.tw.<BR/>17. random$.tw.<BR/>18. exp experimental design/<BR/>19. exp crossover procedure/<BR/>20. exp control group/<BR/>21. exp latin square design/<BR/>22. or/12-21<BR/>23. 22 not 10<BR/>24. 23 not 11<BR/>25. exp comparative study/<BR/>26. exp evaluation/<BR/>27. exp prospective study/<BR/>28. (control$ or prospectiv$ or volunteer$).tw.<BR/>29. or/25-28<BR/>30. 29 not 10<BR/>31. 30 not (11 or 23)<BR/>32. 11 or 24 or 31<BR/>33. exp trabeculectomy/<BR/>34. trabeculectom$.tw.<BR/>35. exp filtering surgery/<BR/>36. (filter$ adj3 surg$).tw.<BR/>37. (filtrat$ adj3 surg$).tw.<BR/>38. (filter$ adj3 bleb$).tw.<BR/>39. (filtrat$ adj3 bleb$).tw.<BR/>40. or/33-39<BR/>41. leak$.tw.<BR/>42. fail$.tw.<BR/>43. ooz$.tw.<BR/>44. or/41-43<BR/>45. 40 and 44<BR/>46. 32 and 45</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2012-02-16 11:50:45 +0000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2012-02-16 11:49:26 +0000" MODIFIED_BY="[Empty name]">
<I>meta</I>Register of Controlled Trials search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-02-16 11:50:45 +0000" MODIFIED_BY="[Empty name]">
<P>trabeculectomy and (fail or leak or ooz)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2012-02-16 11:51:08 +0000" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2012-02-16 11:49:43 +0000" MODIFIED_BY="[Empty name]">ClinicalTrials.gov search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-02-16 11:51:08 +0000" MODIFIED_BY="[Empty name]">
<P>Trabeculectomy AND (Fail OR Leak OR Ooz)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2012-07-23 14:17:13 +0100" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2012-02-16 11:49:55 +0000" MODIFIED_BY="[Empty name]">ICTRP search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-23 14:17:13 +0100" MODIFIED_BY="[Empty name]">
<P>Trabeculectomy = Condition AND Fail OR Leak OR Ooz = Intervention</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study included in the review&lt;/p&gt;" WIDTH="191">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 full-text article assessed for eligibility&lt;/p&gt;" WIDTH="245">
<FLOWCHARTBOX TEXT="&lt;p&gt;289 records screened by the authors&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;950 records screened by the Trials Search Co-ordinator (TSC)&lt;/p&gt;" WIDTH="158">
<FLOWCHARTBOX TEXT="&lt;p&gt;950 records after duplicates removed&lt;/p&gt;" WIDTH="241">
<FLOWCHARTBOX TEXT="&lt;p&gt;1333 records identified through electronic database searching&lt;/p&gt;" WIDTH="206"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;661 records excluded by the TSC after initial screening&lt;/p&gt;" WIDTH="160"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;288 records excluded by authors as not relevant&lt;/p&gt;" WIDTH="163"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>